[Symposium] [GB] Innovative & integrated solution providers in translational research to develop immunotherapies - 30 September - Paris

Toward Next Generation of Solution Providers

[Symposium] [GB] Innovative & integrated solution providers in translational research to develop immunotherapies - 30 Septembre - Paris

Share the symposium with your community #InnovativeSolutionProviders!

The development of immunotherapies faces major challenges such as the inability to predict treatment efficacy and patient response; the need for additional biomarkers; the development of resistance to immunotherapies; the lack of translational tools; the optimization of clinical study designs thanks to precision medicine.

Therefore, expected innovations should include more targeted treatments, the development of personalized biomarker profiles, drug combination therapies to improve efficacy and reduce toxicity.

Open innovation can be tapped and used to open up the necessary and expected innovations thanks to the cross-linking of knowledge and know-how from both Pharma or Biotech industries and external innovation partners.

Within this framework, Oncodesign has built up a network of key partners (Cynbiose, CERB & Aepodia & PharmaLex) convinced that these complex developments require the use of a collaborative and creative research organizations network permitting Pharma or Biotech companies to manage innovative projects from discovery stage to clinical trials. We bring together technological platforms, skills and knowledge, ability to set up an appropriate project governance structure within a comprehensive view of the immunotherapy development process.

The aim of this symposium is to address the current trends in Immunotherapies discovery & development from an academic, industrial and regulatory affairs point of view. It will also allow to depict how collaborative research organizations can bring their added values within this context.

REGISTRATION FORM

Contact us

If you need any additional information, please contact
Florence Fombertasse - Marketing & Communication Manager - Oncodesign

This email address is being protected from spambots. You need JavaScript enabled to view it.


Venez discuter de notre large palette de services et solutions innovantes & les opportunités de licensing ou partenariat en oncologie, immuno-inflammation& maladie neurodégénératives.

[Congress] World Molecular Imaging Conference – 4-7 September - Montreal

World Molecular Imaging Conference – 4-7 Septembre - Montreal

Explore our multi-modal pharmaco-imaging & targeted radiotherapy expetise for your preclinical projects:

  • Design & implementation of the radionuclide labeling of your chemical or biological molecules of interest
  • Biodistribution of therapeutic drugs using non-invasive techniques
  • Development of translational nuclear medicine biomarkers
  • Evaluation of targeted radiotherapy efficacy

Schedule a meeting to discuss your project and investigate how Oncodesign can support your pipeline!

This email address is being protected from spambots. You need JavaScript enabled to view it.


Venez discuter de notre large palette de services et solutions innovantes & les opportunités de licensing ou partenariat en oncologie, immuno-inflammation& maladie neurodégénératives.
%MCEPASTEBIN%

[Congress] Nordic Life Science Days - 10-12 September - Malmö, Copenhagen

[Congrès] Nordic Life Science Days - 10-12 Septembre - Malmö, Copenhague

 Looking for a partner that allows you to validate the efficacy of your molecule with proven proof of concept?

To find out more, meet Mike Brown, our sales manager, via the One-on-One partnership platform. He will present our expertise in vitro / vivo pharmacology, imaging & RTR, biomarkers as well as our offer in DMPK and bioanalysis performed in GLP environment.

All our offers are available for your therapeutic projects in inflammation, immunology, immuno-oncology, oncology and infectious diseases.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Access One-on-One Partnering platform

 

Nos expert seront présents:

Table ronde "Quoi de neuf autour de l’innovation en oncologie ? » Avec la participation de Mr. Sébastien Vachenc Responsable Data Sciences et Directeur de projet OncoSNIPE®

Session de Networking où nous dévoilerons nos compétences en oncologie/IO dans le cadre de notre consortium IMODI ainsi que notre large palette d’offres pour les maladies inflamatoires et maladies infectieuses ( depuis l’identification de cibles, la phase d’optimisation à la demande d’investigation du nouveau medicament (IND))

Oncodesign vous guide tout au long des processus de développement de votre candidat médicament.
A l'occasion du congrès annuel SNMMI, nous vous dévoilons notre expertise en pharmaco-imagerie et radiothérapie ciblée.

[Congress] ELRIG Discovery Technologies - 26 September - Alderley Park, Cheshire

[Congress] ELRIG Discovery Technologies - 26 September - Alderley Park, Cheshire - United-Kingdom

Interested in Integrated Drug Discovery partner or services?

Meet our experts during ELRIG to checkout our unique Drug Discovery platform from patient to diagnostic and across various therapeutic areas
(Oncology, Inflammation, Immunology and Dermatology).
Find out how our multi-disciplinary teams and best-in-class expertise can help you get to IND faster!

This email address is being protected from spambots. You need JavaScript enabled to view it.


Venez discuter de notre large palette de services et solutions innovantes & les opportunités de licensing ou partenariat en oncologie, immuno-inflammation& maladie neurodégénératives.

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.